We are live on ! Find out more
QUSVM

Qiming U.S. Ventures Management Portfolio holdings

AUM $55.6M
1-Year Est. Return 98.09%
This Fund
S&P 500
This Quarter Est. Return
+54.48%
1 Year Est. Return
+98.09%
3 Year Est. Return
+1,484.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$82.6M
AUM Growth
+$7.03M
Cap. Flow
+$4.93M
Cap. Flow %
5.97%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
JSPR icon
Jasper Therapeutics
JSPR
+$4.93M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTYX
1
DELISTED
Ventyx Biosciences
VTYX
$25M 30.26%
746,370
– –
ICVX
2
DELISTED
Icosavax, Inc. Common Stock
ICVX
$20.4M 24.64%
3,510,228
– –
JSPR icon
3
Jasper Therapeutics
JSPR
$22.9M
$15.4M 18.66%
851,965
+266,667
+46% +$4.93M
HLVX
4
DELISTED
HilleVax
HLVX
$9.24M 11.18%
558,923
– –
TRML
5
DELISTED
Tourmaline Bio
TRML
$5.51M 6.67%
293,261
– –
ELEV
6
DELISTED
Elevation Oncology
ELEV
$4.5M 5.45%
2,370,142
– –
KZR
7
DELISTED
Kezar Life Sciences
KZR
$2.59M 3.14%
82,871
– –

Similar funds

CCCPV
Castle Creek Capital Partners VI San Diego, California $55.9M AUM 7.91% 1-Year Est. Return
ACM
Aurelius Capital Management New York $55.2M AUM 124.79% 1-Year Est. Return
SGA
Siguler Guff Advisers New York $56.1M AUM 46.63% 1-Year Est. Return
NCFG
New Century Financial Group Princeton, New Jersey $56.3M AUM 16.99% 1-Year Est. Return
LAM
Lingohr Asset Management Duesseldorf, Germany $57.3M AUM 35.27% 1-Year Est. Return
ST
Skorpios Trust Limassol, Cyprus $53.2M AUM 90.96% 1-Year Est. Return
ITVII
IDG Technology Venture Investment IV Hong Kong $58.3M AUM 89.42% 1-Year Est. Return
MCP
Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Qiming U.S. Ventures Management's Q1 2023 Portfolio in Review

As of Q1 2023, Qiming U.S. Ventures Management held 7 positions worth $82.6M, up 9.3% from $75.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Qiming U.S. Ventures Management deployed $4.93M of net new capital in Q1 2023, adding to 1 existing holding.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Qiming U.S. Ventures Management added most to Jasper Therapeutics in Q1 2023, an estimated $4.93M increase.
  • Qiming U.S. Ventures Management's ten largest holdings make up 100% of its $82.6M portfolio in Q1 2023.
  • Qiming U.S. Ventures Management opened 0 new positions and closed 0 in Q1 2023.
  • Qiming U.S. Ventures Management's portfolio value rose 9.3% quarter-over-quarter to $82.6M.

Based on Qiming U.S. Ventures Management's 13F filing for Q1 2023, filed 25 Apr 2023.